Blood eosinophil count and exacerbation risk in patients with COPD.

@article{Kerkhof2017BloodEC,
  title={Blood eosinophil count and exacerbation risk in patients with COPD.},
  author={M Kerkhof and Samatha Sonnappa and Dirkje S Postma and Guy G Brusselle and Alvar Agust{\'i} and Antonio Anzueto and Rupert C. M. Jones and Alberto Papi and Ian D. Pavord and Emilio Pizzichini and Todor A Popov and Nicolas Roche and Dermot Ryan and Mike Thomas and Claus Vogelmeier and Alison Chisholm and Daryl Freeman and Mona Bafadhel and Elizabeth V Hillyer and David B. Price},
  journal={The European respiratory journal},
  year={2017},
  volume={50 1}
}
  • M Kerkhof, Samatha Sonnappa, +17 authors David B. Price
  • Published in
    The European respiratory…
    2017
  • Medicine
  • Support statement: support was provided by the Respiratory Effectiveness Group (REG-RES1306). Funding information for this article has been deposited with the Crossref Funder Registry. 

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    41
    Twitter Mentions

    Tables and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 13 CITATIONS

    Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort

    VIEW 1 EXCERPT
    CITES RESULTS

    Blood eosinophil count as a prognostic biomarker in COPD

    VIEW 1 EXCERPT
    CITES METHODS

    Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 15 REFERENCES

    inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

    • H Watz, K Tetzlaff, EF Wouters
    • Lancet Respir Med
    • 2015